EZH2 and B-cell non-Hodgkin lymphoma: Furthermore, two cell lines from the B-cell lymphoma background with high interest in EZH2 inhibition were used for comparison as they either carry an activating EZH2 mutation or show high EZH2 expression, respectively [35,36].